Patents by Inventor John Mikszta

John Mikszta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040077994
    Abstract: Improved microprotrusion abrasion devices having fluid retaining or directing patterns, and specific design parameters and method for delivery of substances into the skin. Various configurations of such devices are disclosed, including domed, channeled, patterned and stepped.
    Type: Application
    Filed: August 27, 2003
    Publication date: April 22, 2004
    Inventors: Alexander G. Lastovich, Jason B. Alarcon, John P. Dekker, M. Ishaq Haider, John A. Mikszta, Frank E. Martin, Scott A. O'Connor
  • Publication number: 20030191085
    Abstract: The present invention provides improved methods for delivery of substances into the skin. It has been discovered that delivery of substances such as nucleic acids, amino acids, amino acid derivatives, peptides and polypeptides simultaneously with abrasion of the skin enhances delivery and the biological response as compared to application of the substance to previously abraded skin.
    Type: Application
    Filed: May 13, 2003
    Publication date: October 9, 2003
    Inventors: John A. Mikszta, John M. Brittingham, Jason Alarcon, Ronald J. Pettis, John P. Dekker
  • Publication number: 20030186271
    Abstract: A method of preparing a pharmaceutical composition is described, comprising 1) atomizing a liquid formulation of a therapeutic agent to produce an atomized formulation; 2) freezing said atomized formulation to form solid particles; and 3) drying said solid particles at about atmospheric pressure to produce a powder, wherein said drying is performed in the presence of vibration, internals, mechanical stirring, or a combination thereof. Another method is described, comprising 1) atomizing a liquid formulation of a therapeutic agent to produce an atomized formulation; 2) freezing said atomized formulation to form solid particles; and 3) drying said solid particles to produce a powder; wherein the atomized formulation comprises droplets having an average mean diameter of between about 35&mgr; and about 300&mgr;, and/or the powder comprises dried particles having an average mean diameter of between about 35&mgr; and about 300&mgr;.
    Type: Application
    Filed: November 19, 2002
    Publication date: October 2, 2003
    Inventors: Robin Hwang, Vincent Sullivan, Juan Huang, Zhaolin Wang, John A. Mikszta, David Montgomery, Brandi Ford, Anjana Bhuta-Wills
  • Publication number: 20030180755
    Abstract: A method of preparing a pharmaceutical composition is described, comprising 1) atomizing a liquid formulation of a therapeutic agent to produce an atomized formulation; 2) freezing said atomized formulation to form solid particles; and 3) drying said solid particles at about atmospheric pressure to produce a powder, wherein said drying is performed in the presence of vibration, internals, mechanical stirring, or a combination thereof. Another method is described, comprising 1) atomizing a liquid formulation of a therapeutic agent to produce an atomized formulation; 2) freezing said atomized formulation to form solid particles; and 3) drying said solid particles to produce a powder; wherein the atomized formulation comprises droplets having an average mean diameter of between about 35&mgr; and about 300&mgr;, and/or the powder comprises dried particles having an average mean diameter of between about 35&mgr; and about 300&mgr;.
    Type: Application
    Filed: November 19, 2002
    Publication date: September 25, 2003
    Inventors: Robin Hwang, Vincent Sullivan, Juan Huang, Zhaolin Wang, John A. Mikszta, David Montgomery, Brandi Ford, Anjana Bhuta-Wills
  • Publication number: 20030138434
    Abstract: The invention relates to an immunogenic composition and methods of making and using the composition. The immunogenic composition contains a directing molecule, a stimulant and an immunogen. The stimulant and directing molecule are chemically distinct. The stimulant and immunogen are present in relative amounts to result in an improved immune response relative to that resulting from the immunogen and just one of the directing molecule or stimulant.
    Type: Application
    Filed: May 13, 2002
    Publication date: July 24, 2003
    Inventors: Robert L. Campbell, John A. Mikszta
  • Patent number: 6595947
    Abstract: A method for delivering a substance to the epidermal tissue of skin. The method involves simultaneously disrupting only the stratum corneum of the skin and delivering the substance to the epidermal tissue of the skin.
    Type: Grant
    Filed: May 22, 2000
    Date of Patent: July 22, 2003
    Assignee: Becton, Dickinson and Company
    Inventors: John A. Mikszta, John M. Brittingham, Jason Alarcon, Ronald J. Pettis, John P. Dekker, III
  • Publication number: 20030093040
    Abstract: An abrasion device and method for delivery of substances into the skin comprises a microabrader for delivering a substance into the skin having a base with an abrading facet, to which an abrading surface having an arrangement of microprotrusions that have at least one scraping edge is attached, mounted, or integral with and a handle attachment facet, to which a handle or other grasping device is attached or mounted.
    Type: Application
    Filed: October 29, 2002
    Publication date: May 15, 2003
    Inventors: John A. Mikszta, John M. Brittingham, Jason Alarcon, John P. Dekker, Ronald J. Pettis
  • Publication number: 20020198509
    Abstract: Methods and devices for administration of vaccines and gene therapeutic agents into the intradermal layer of skin.
    Type: Application
    Filed: July 1, 2002
    Publication date: December 26, 2002
    Inventors: John A. Mikszta, Jason B. Alarcon, Paul G. Alchas